Session Description

Join Eisai for a virtual symposium focusing on the central role of amyloid beta (Aβ) in the pathophysiology of Alzheimer’s disease (AD). Our expert faculty will provide a comprehensive overview of the evidence supporting Aβ alteration as an early event within the AD continuum, as well as a presentation of the latest developments regarding in vivo biomarkers of Aβ. The program will begin by reviewing the genetic evidence supporting a role for Aβ in AD, and cover the different Aβ species and their roles in brain toxicity. Finally, we will discuss the latest developments concerning in vivo biomarkers of Aβ, as well as amyloid positron emission tomography imaging and cerebrospinal fluid measures of Aβ dyshomeostasis.